Fractional exhaled nitric oxide moderately accurate to diagnose asthma

January 2, 2018

(HealthDay)—Fractional exhaled nitric oxide (FeNO) measurement can diagnose asthma in individuals aged 5 years and older with moderate accuracy, according to a review published online Dec. 20 in Mayo Clinic Proceedings.

Zhen Wang, Ph.D., from the Mayo Clinic in Rochester, Minn., and colleagues conducted a systematic literature review to identify studies that evaluated FeNO diagnostic accuracy in patients ≥5 years with suspected asthma.

The researchers included 43 studies with a total of 13,747 patients. Using FeNO cutoffs of <20, 20 to 29, 30 to 39, and 40 or more parts per billion, FeNO testing yielded sensitivities of 0.8, 0.69, 0.53, and 0.41, respectively, and specificities of 0.64, 0.78, 0.85, and 0.93, respectively, in adults. By comparison, using FeNO cutoffs of <20 and 20 to 29 parts per billion in children yielded sensitivities of 0.78 and 0.61, respectively, and specificities of 0.79 and 0.89, respectively. In corticosteroid-naive asthma , children, and nonsmokers, the diagnostic accuracy was modestly better than in the overall population.

"Fractional exhaled measurement has moderate accuracy to diagnose in individuals aged 5 years and older," the authors write.

Explore further: Another test to help clinicians diagnose asthma more accurately

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Another test to help clinicians diagnose asthma more accurately

December 21, 2017
Although about 24 million Americans are diagnosed with asthma every year, there is no single test that can diagnose the disease. Common symptoms, such as shortness of breath, wheezing, and cough, are relatively nonspecific, ...

Decreased clot retraction rate in asthma

November 7, 2016
(HealthDay)—Clot retraction rate (CRR) and fibrinolysis rate (FR) are reduced in steroid-naive asthma, according to a study published online Oct. 14 in Allergy.

ATS publishes clinical practice guidelines on interpretation of FENO levels

September 1, 2011
The American Thoracic Society has issued the first-ever guidelines on the use of fractional exhaled nitric oxide (FENO) that address when to use FENO and how to interpret FENO levels in different clinical settings. The guidelines, ...

Two tests in combination can provide better asthma diagnosis

September 24, 2013
It was previously thought that the two test methods signalled the same type of asthma. But a new study, led by researchers at Uppsala University, Sweden, shows that the methods actually signal two different inflammatory processes. ...

Smoking a single cigarette may have immediate effect on young adults

October 24, 2011
It is well known that smoking leads to a reduction in levels of fractional exhaled nitric oxide (FeNO), which is a marker for airway inflammation.

Atopic dermatitis associated with higher risk of skin cancer

December 29, 2017
(HealthDay)—Atopic dermatitis (AD) is associated with an increased risk of developing squamous cell carcinoma (SCC), according to a study published online Dec. 15 in the International Journal of Dermatology.

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.